Skip to main content
. 2017 Oct 5;8(61):103499–103508. doi: 10.18632/oncotarget.21498

Table 1. Clinical characteristics of the IS patients and the control group.

Characteristics Controls (n = 443) Cases (n = 392) P value
Age, (M ± SD, year) 60.7 ± 10.3 61.8 ± 10.1 0.329
Gender, (%)
 Male 278 (62.8) 256 (65.3)
 Female 165 (37.2) 136 (34.7) 0.443
Diabetes, (%)
 Yes 46 (10.4) 74 (18.9)
 No 397 (89.6) 318 (81.1) <0.001
Hypertension, (%)
 Yes 112 (25.3) 249 (63.5)
 No 331 (74.7) 143 (36.5) <0.001
TG, (mmol/L) 1.07 ± 0.42 1.70 ± 1.24 <0.001
LDL-C, (mmol/L) 2.49 ± 0.50 3.02 ± 0.76 <0.001
HDL-C, (mmol/L) 1.74 ± 0.37 1.28 ± 0.33 <0.001
TCH, (mmol/L) 4.83 ± 0.69 5.07 ± 0.93 0.024

M ± SD, mean ± standard deviation; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TCH, total cholesterol.